PL3.3 Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion

Martin J. van den Bent, Pim J. French, Michael A. Vogelbaum et al.|Neuro-Oncology|2019

Cited by 29